@article{TAU6086,
author = {Katie Canalichio and Yasmeen Jaber and Run Wang},
title = {Surgery and hormonal treatment for prostate cancer and sexual function},
journal = {Translational Andrology and Urology},
volume = {4},
number = {2},
year = {2015},
keywords = {},
abstract = {Prostate cancer (PC) is one of the most common cancers effecting men today. With earlier detection and improvements in available treatment modalities, there still remains significant morbidity associated with the treatment of PC. Male sexual health and erectile function are greatly impacted by these therapies and remain a concern to PC survivors. This article reviews the current literature on male sexual health following radical prostatectomy (RP) or androgen ablation therapy for PC. Each treatment modality affects male sexual function to an appreciable level, although certain patients have better outcomes if they have preoperative potency, are younger, or have nerve-sparing surgery. There is a delayed recovery up to 2 years seen in erectile function following RP. With androgen deprivation therapy (ADT), attempts can be made at different administration strategies and exercise may possibly play a role in maintaining erectile function. Penile rehabilitation protocols attempt to protect erectile function immediately following therapy through different modalities, although no one approach has been agreed upon.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/6086}
}